Published in Allergy on November 18, 2010
International consensus on (ICON) pediatric asthma. Allergy (2012) 1.79
The role of airway epithelial cells and innate immune cells in chronic respiratory disease. Nat Rev Immunol (2014) 1.25
Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. J Clin Invest (2012) 1.24
The microbiology of asthma. Nat Rev Microbiol (2012) 1.14
The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial. Am J Respir Crit Care Med (2014) 1.11
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
Allergy as an epithelial barrier disease. Clin Transl Allergy (2011) 0.96
Social, economic, and health impact of the respiratory syncytial virus: a systematic search. BMC Infect Dis (2014) 0.94
Intensive care unit patients with 2009 pandemic influenza A (H1N1pdm09) virus infection - United States, 2009. Influenza Other Respir Viruses (2012) 0.93
Clinical profile of recurrent community-acquired pneumonia in children. BMC Pulm Med (2013) 0.91
Replication and Inhibitors of Enteroviruses and Parechoviruses. Viruses (2015) 0.89
The immune profile associated with acute allergic asthma accelerates clearance of influenza virus. Immunol Cell Biol (2014) 0.88
Budesonide and formoterol reduce early innate anti-viral immune responses in vitro. PLoS One (2011) 0.85
Influenza A(H1N1)pdm09 virus and asthma. Front Microbiol (2013) 0.85
Rhino/enteroviruses in hospitalized children: a comparison to influenza viruses. J Clin Virol (2012) 0.83
Tailored therapy for severe asthma. Multidiscip Respir Med (2015) 0.83
Epidemiology and associations with climatic conditions of Mycoplasma pneumoniae and Chlamydophila pneumoniae infections among Chinese children hospitalized with acute respiratory infections. Ital J Pediatr (2013) 0.82
Toll-like receptor ligands LPS and poly (I:C) exacerbate airway hyperresponsiveness in a model of airway allergy in mice, independently of inflammation. PLoS One (2014) 0.82
The importance of bacterial and viral infections associated with adult asthma exacerbations in clinical practice. PLoS One (2015) 0.81
Use of sensitive, broad-spectrum molecular assays and human airway epithelium cultures for detection of respiratory pathogens. PLoS One (2012) 0.81
Rhinovirus and serum IgE are associated with acute asthma exacerbation severity in children. J Allergy Clin Immunol (2016) 0.80
NOD-like receptors mediated activation of eosinophils interacting with bronchial epithelial cells: a link between innate immunity and allergic asthma. Cell Mol Immunol (2013) 0.80
High degree of overlap between responses to a virus and to the house dust mite allergen in airway epithelial cells. PLoS One (2014) 0.80
Aberrant expression of regulatory cytokine IL-35 and pattern recognition receptor NOD2 in patients with allergic asthma. Inflammation (2015) 0.79
Evaluation of pulmonary dysfunctions and acid-base imbalances induced by Chlamydia psittaci in a bovine model of respiratory infection. Multidiscip Respir Med (2014) 0.77
Specific Induction of TSLP by the Viral RNA Analogue Poly(I:C) in Primary Epithelial Cells Derived from Nasal Polyps. PLoS One (2016) 0.77
Changes in levels of IL-9, IL-17, IFN-γ, dendritic cell numbers and TLR expression in peripheral blood in asthmatic children with Mycoplasma pneumoniae infection. Int J Clin Exp Pathol (2015) 0.77
Inactivated influenza virus vaccine is efficient and reduces IL-4 and IL-6 in allergic asthma mice. Influenza Other Respir Viruses (2013) 0.76
Human and Mouse Eosinophils Have Antiviral Activity against Parainfluenza Virus. Am J Respir Cell Mol Biol (2016) 0.76
Versican deficiency significantly reduces lung inflammatory response induced by polyinosine-polycytidylic acid stimulation. J Biol Chem (2016) 0.75
Anti-inflammatory effects of the novel inhaled phosphodiesterase type 4 inhibitor CHF6001 on virus-inducible cytokines. Pharmacol Res Perspect (2016) 0.75
Severe acute asthma caused by Chlamydophila pneumoniae infection. Respirol Case Rep (2017) 0.75
Synergistic Effect of Dermatophagoides farinae and Lipopolysaccharides in Human Middle ear Epithelial Cells. Allergy Asthma Immunol Res (2016) 0.75
Impacts of allergic airway inflammation on lung pathology in a mouse model of influenza A virus infection. PLoS One (2017) 0.75
Association of hospitalizations for asthma with seasonal and pandemic influenza. Respirology (2014) 0.75
Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science (1987) 13.52
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08
Eosinophilic inflammation in asthma. N Engl J Med (1990) 8.05
Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med (1990) 7.46
Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J Virol (1990) 6.54
A self management plan in the treatment of adult asthma. Thorax (1989) 5.85
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet (2001) 5.25
Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 5.17
A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy (2001) 5.07
Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med (1999) 4.72
Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis (1985) 4.59
Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell (2001) 4.25
A soluble CD4 protein selectively inhibits HIV replication and syncytium formation. Nature (1988) 4.15
Mucosal inflammation in asthma. Am Rev Respir Dis (1990) 4.11
Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis (1989) 3.86
Randomised comparison of guided self management and traditional treatment of asthma over one year. BMJ (1996) 3.79
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface. J Cell Biol (1999) 3.59
Allergenic pollen and pollen allergy in Europe. Allergy (2007) 3.58
Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet (2000) 3.44
Prevalence of respiratory symptoms among 7 and 11 year old schoolchildren and association with asthma. Arch Dis Child (1989) 3.25
Role of nonallergic hypersensitivity reactions in children with chronic urticaria. Allergy (1998) 3.20
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy (2014) 3.10
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10
Integrated cytogenetic map of chromosome arm 4S of A. thaliana: structural organization of heterochromatic knob and centromere region. Cell (2000) 3.04
Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01
No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy (2002) 2.99
Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ (2000) 2.97
Cis-acting sequences responsive to the rev gene product of the human immunodeficiency virus. J Acquir Immune Defic Syndr (1988) 2.97
The diagnosis and management of chronic cough. Eur Respir J (2004) 2.96
Induction of nitric oxide synthase in asthma. Lancet (1994) 2.93
T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol (1996) 2.92
The Brussels Declaration: the need for change in asthma management. Eur Respir J (2008) 2.91
Rhinoviruses infect the lower airways. J Infect Dis (2000) 2.83
Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann Neurol (1994) 2.82
Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J (2010) 2.77
Primary prevention of food allergy in children and adults: systematic review. Allergy (2014) 2.75
Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol (1994) 2.73
Standards for practical allergen-specific immunotherapy. Allergy (2006) 2.70
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
Protection against allergen-induced asthma by salmeterol. Lancet (1990) 2.51
Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51
Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med (1995) 2.48
Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol (2000) 2.48
Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47
Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis (1990) 2.45
Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J (2000) 2.42
Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis (2004) 2.41
Age specific trends in asthma mortality in England and Wales, 1983-95: results of an observational study. BMJ (1997) 2.40
Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J (2011) 2.38
Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med (2000) 2.36
Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med (1998) 2.36
Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy (2010) 2.34
Daily versus as-needed inhaled corticosteroid for mild persistent asthma (The Helsinki early intervention childhood asthma study). Arch Dis Child (2007) 2.33
Phylogeny of nitrogenase sequences in Frankia and other nitrogen-fixing microorganisms. J Mol Evol (1989) 2.33
Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der p1. Am J Respir Cell Mol Biol (1995) 2.30
Neurologic manifestations of atrial myxoma. A 12-year experience and review. Stroke (1988) 2.30
Determinants of sciatica and low-back pain. Spine (Phila Pa 1976) (1991) 2.29
Personal exposures of children to nitrogen dioxide relative to concentrations in outdoor air. Occup Environ Med (2000) 2.29
Improving the quality of health care: using international collaboration to inform guideline programmes by founding the Guidelines International Network (G-I-N). Qual Saf Health Care (2004) 2.28
Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin Exp Allergy (1992) 2.28
Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2005) 2.26
Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis. Leukemia (2013) 2.25